Inventor · disambiguated record
John Devane
Also filed as: DEVANE JOHN · DEVANE JOHN G · DEVANE JOHN GERARD
26 granted patents·49 pending applications·1,429 citations·filing 1999–2025
96Inventor score
Files withELAN CORP PLC10ELAN PHARMA INT LTD9AMNEAL PHARMACEUTICALS LLC7DEVANE JOHN7AGI THERAPEUTICS LTD6
Top patents by PatentIndex Score
75 records- 0197US6902742B2Multiparticulate modified release compositionELAN CORP PLC·Filed 2002·Granted Jun 7, 2005·236 cites·31 claims
- 0297US6793936B2Multiparticulate modified release compositionELAN CORP PLC·Filed 2003·Granted Sep 21, 2004·211 cites·31 claims
- 0397US6730325B2Multiparticulate modified release compositionELAN CORP PLC·Filed 2001·Granted May 4, 2004·277 cites·28 claims
- 0497US6228398B1Multiparticulate modified release compositionELAN CORP PLC·Filed 2000·Granted May 8, 2001·570 cites·37 claims
- 0594US11491125B1Baclofen formulations and methods of minimizing patient exposure to metabolite variationsAMNEAL PHARMACEUTICALS LLC·Filed 2021·Granted Nov 8, 2022·3 cites·20 claims
- 0689US11654124B2Stabilized formulations of 4-amino-3-substituted butanoic acid derivativesAMNEAL PHARMACEUTICALS LLC·Filed 2020·Granted May 23, 2023·2 cites·13 claims
- 0788US10792262B1Stabilized formulations of 4-amino-3-substituted butanoic acid derivativesSAOL INTERNATIONAL LTD·Filed 2019·Granted Oct 6, 2020·7 cites·23 claims
- 0887US8119163B2Nanoparticulate and controlled release compositions comprising cefditorenDEVANE JOHN G·Filed 2007·Granted Feb 21, 2012·15 cites·22 claims
- 0987US7413751B2Methods of treatment using a gastric retained losartan dosageDEPOMED INC·Filed 2002·Granted Aug 19, 2008·31 cites·20 claims
- 1082US12383522B2Baclofen formulations and methods of minimizing patient exposure to metabolite variationsAMNEAL PHARMACEUTICALS LLC·Filed 2023·Granted Aug 12, 2025·0 cites·16 claims
- 1181US7737133B2Formulations and methods of treating inflammatory bowel diseaseAGI THERAPEUTICS LTD·Filed 2004·Granted Jun 15, 2010·19 cites·10 claims
- 1279US8293277B2Controlled-release nanoparticulate compositionsSWANSON JON·Filed 1999·Granted Oct 23, 2012·45 cites·28 claims
- 1377US11850225B2Baclofen formulations and methods of minimizing patient exposure to metabolite variationsAMNEAL PHARMACEUTICALS LLC·Filed 2022·Granted Dec 26, 2023·0 cites·19 claims
- 1475US12011502B2Compositions and methods of administering baclofenAMNEAL PHARMACEUTICALS LLC·Filed 2022·Granted Jun 18, 2024·0 cites·12 claims
- 1575US11931328B2Stabilized formulations of 4-amino-3-substituted butanoic acid derivativesAMNEAL PHARMACEUTICALS LLC·Filed 2023·Granted Mar 19, 2024·0 cites·18 claims
- 1671US6849661B2Treatment of abnormal increases in gastrointestinal motility with (R)-verapamilAGI THERAPEUTICS LTD·Filed 2002·Granted Feb 1, 2005·8 cites·29 claims
- 1769US11083695B2Injectable phenol formulations and methods of manufactureSAOL INT DEVELOPMENT LTD·Filed 2021·Granted Aug 10, 2021·0 cites·19 claims
- 1869US11083694B2Injectable phenol formulations and methods of their useSAOL INT DEVELOPMENT LTD·Filed 2021·Granted Aug 10, 2021·0 cites·19 claims
- 1967US11523984B1Compositions and methods of administering baclofenAMNEAL PHARMACEUTICALS LLC·Filed 2021·Granted Dec 13, 2022·0 cites·14 claims
- 2066US7928092B2Formulations and methods of treating inflammatory bowel diseaseAGI THERAPEUTICS LTD·Filed 2010·Granted Apr 19, 2011·1 cites·9 claims
- 2166US2009297619A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2009·Application pending·0 cites
- 2265US10959962B2Injectable phenol formulations and methods of their useSAOL INT DEVELOPMENT LTD·Filed 2020·Granted Mar 30, 2021·0 cites·10 claims
- 2365US9040591B2Methods and compositions comprising at least one α3 βA4 nAChR antagonist or pharmaceutically acceptable salt thereofDEVANE JOHN·Filed 2012·Granted May 26, 2015·1 cites·12 claims
- 2465US8236352B2Glipizide compositionsBOSCH H WILLIAM·Filed 2003·Granted Aug 7, 2012·1 cites·49 claims
- 2563US6967218B2Pravastatin pharmaceutical formulations and methods of their useBIOVAIL LAB INC·Filed 2003·Granted Nov 22, 2005·2 cites·57 claims
- 2662US2008248123A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2008·Application pending·0 cites
- 2762US2011008435A1Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic CompoundsELAN CORP PLC·Filed 2007·Application pending·0 cites
- 2861US2008124393A1Controlled release nanoparticulate compositionsELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 2961US2006240105A1Multiparticulate modified release compositionELAN CORP PLC·Filed 2006·Application pending·0 cites
- 3060US2008207766A1Methods and compositions for treating at least one upper gastrointestinal symptomAGI THERAPEUTICS RES LTD·Filed 2008·Application pending·0 cites
- 3158US2004197405A1Multiparticulate modified release compositionELAN CORP PLC·Filed 2004·Application pending·0 cites
- 3258US2007048378A1Nanoparticulate anticonvulsant and immunosuppressive compositionsELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 3357US8987322B2Pharmaceutical formulations for carrier-mediated transport statins and uses thereofBUTLER JACKIE·Filed 2004·Granted Mar 24, 2015·0 cites·8 claims
- 3457US2009246233A1Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB AgonistsAGI THERAPEUTICS RES LTD·Filed 2009·Application pending·0 cites
- 3556US2008113025A1Compositions comprising nanoparticulate naproxen and controlled release hydrocodoneELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 3656US2008102121A1Compositions comprising nanoparticulate meloxicam and controlled release hydrocodoneELAN PHARMA INT LTD·Filed 2007·Application pending·0 cites
- 3754US2010247636A1Nanoparticulate and controlled release compositions comprising nilvadipineELAN CORP PLC·Filed 2006·Application pending·0 cites
- 3854US2008118556A1Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and EntacaponeELAN CORP PLC·Filed 2006·Application pending·0 cites
- 3954US2007160675A1Nanoparticulate and controlled release compositions comprising a cephalosporinELAN CORP PLC·Filed 2006·Application pending·0 cites
- 4053US2005232992A1Proton pump inhibitor formulations, and methods of preparing and using such formulationsAGI THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 4153US2017000783A1Multiparticulate Modified Release CompositionRECRO TECH LLC·Filed 2016·Application pending·0 cites
- 4253US2011300210A1Controlled release nanoparticulate clozapine compositionsSWANSON JON·Filed 2011·Application pending·0 cites
- 4352US2009297596A1Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation InhibitorELAN PHARMA INT LTD·Filed 2006·Application pending·0 cites
- 4452US2025369974A1Method for monitoring and preventing clinically significant ketone levels in patients receiving dichloroacetate co-administered with a carbohydrate restricted dietSAOL INT DEVELOPMENT LTD·Filed 2025·Application pending·0 cites
- 4552US2007224284A1Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereofDEVANE JOHN·Filed 2007·Application pending·0 cites
- 4652US2013011447A1Controlled release nanoparticulate compositionsALKERMES PHARMA IRELAND LTD·Filed 2012·Application pending·0 cites
- 4751US2009297597A1Modified Release Ticlopidine CompositionsLIVERSIDGE GARY·Filed 2006·Application pending·0 cites
- 4850US2005090554A1Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonistsFiled 2004·Application pending·0 cites
- 4950US2003091633A1Methods and compositions for use of (S)-bisoprololFiled 2002·Application pending·0 cites
- 5050US2009062242A1Methods and compositions for treating gastrointestinal conditionsAGI THERAPEUTICS PLC·Filed 2008·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →